Q-Linea
Sweden - UppsalaBiotechnology
Focus: Q-Linea is a Swedish biotech company specializing in blood analysis devices, operating as a public company since 2008. The company focuses on diagnostic instrumentation for clinical microbiology and infectious disease detection.
Profile data last refreshed 21h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
1+1 this month
Stable — net +1 jobs in 30d
1 added, 0 removed. Backfill posture.
Should You Work at Q-Linea?
AI assessmentEarly-career professionals should approach cautiously due to hiring freeze and unclear financial/operational status; best suited for diagnostics specialists with tolerance for small-cap volatility.
Why Work Here
- Publicly traded status provides equity upside potential and established capital markets validation for a device-focused biotech
- 15+ years of operational history (founded 2008) indicates sustained business model and market traction in diagnostics
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Q-Linea
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.